Missy Krasner, Executive in Residence (EIR), Morgenthaler Ventures
Missy joins Morgenthaler Ventures with more than twenty years of product development and marketing, business development, and policy experience in healthcare and health information technology. Missy worked at Google for 5 years in health and consumer marketing. Prior to her role at Google, Missy worked for the Bush Administration in the Secretary’s Office at the U.S. Department of Health and Human Services (HHS). Before coming to HHS, she worked as Product Marketing Director for CareScience. Missy previously led the Communications and Research at the Kaiser Family Foundation, a non-partisan, national, healthcare policy think tank. She is also a mentor at 500 Startups and a mentor at Health Box, a new healthcare accelerator out of Chicago, IL. She also advises several health 2.0 startup companies in the Silicon Valley. She has published a series of articles and blogs and is a member of HIMSS, served on the CCHIT Task Force on PHRs, the Lance Armstrong International Advisory Council, and the Planned Parenthood International Marketing Advisory Council.
Rebecca Lynn, Partner, Morgenthaler Ventures
Rebecca is a partner at Morgenthaler Ventures where she focuses on early-stage investments in health IT, mobile, Internet services and financial services. She serves on the boards of Practice Fusion, Lending Club, Socrata, and Pageonce. Rebecca began her career at Procter and Gamble and focused on international new product market entry. She then joined NextCard where she served as the vice president of marketing, managing one of the top-five largest online marketing efforts at the time. Rebecca passed the California State Bar and has a focus on intellectual property litigation and corporate law. Rebecca is an inventor on several issued patents. She was also published in the Berkeley Law and Technology Journal.
Ching Wu, VP Marketing & Investor Relations, Morgenthaler Ventures
Ching is the vice president of marketing at Morgenthaler Ventures where she manages Morgenthaler’s communications with press, portfolio companies and entrepreneurs. Previous to joining Morgenthaler, she worked at startups (served as director of MarCom at Marimba and director of marketing at Illustra Technologies), big companies (senior MarCom roles at Sun Microsystems in the US and Asia) and agencies (account executive at Ogilvy & Mather). She has a B.S. in international politics from Georgetown University’s School of Foreign Service and has served as a guest lecturer on global entrepreneurial marketing at Stanford University’s Department of Management Science and Engineering.
Matthew Holt, Blogger/Founder, Health 2.0
Matthew is the founder of The Health Care Blog and a co-founder of the Health 2.0 Conference, the leading showcase of innovative technologies in health care. With over 20 years in the industry as a generalist forecaster and strategist, he has worked for renowned forecasting and polling organizations, conducted several ground breaking in-depth studies about many aspects of health care, and delivered several keynote addresses. Matt specializes in health IT, pharmaceuticals, health plans and policy issues.
Indu Subaiya, MD, MBA, Co-Chairman and CEO of Health 2.0
Indu Subaiya, MD, MBA is Co-Chairman and CEO of Health 2.0: User Generated Healthcare, a first-of-its-kind forum showcasing leading edge digital media, web and mobile technologies in healthcare. She also is creator of the Health 2.0 Developer Challenge. Most recently she was Entrepreneur-in-Residence at Physic Ventures, a consumer health and wellness investment fund. Prior to that she served as President of Etude Scientific, a consulting firm providing strategy, market assessment, and due diligence services to biotechnology and consumer healthcare companies. Indu also was Vice President of Healthcare and Biomedical Research at Gerson Lehrman Group where she facilitated due diligence research in the life sciences sector for investment fund managers. Earlier in her career she served as Director of Outcomes Research at Quorum Consulting, Inc. where she conducted Phase III-IV quality of life and pharmacoeconomic studies and advised life science clients on commercialization and reimbursement strategies. Indu received her MD from Stony Brook University School of Medicine at the State University of New York, an MBA from the Haas School of Business at the University of California, Berkeley, and a BS in Science and Technology Studies from Cornell University.